Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Olanzapine for CINV Prevention in MEC
NCT02400866Phase 2Unknown
- Sponsor
- Korean South West Oncology Group
- Start
- May 2015
- Primary completion
- Nov 2015
- Modality
- Small Molecules
01
Overview
A Phase 2 trial of olanzapine in chemotherapy-induced nausea and vomiting (CINV), sponsored by Korean South West Oncology Group. Status: unknown.
02
Drugs
olanzapine
03
Conditions
chemotherapy-induced nausea and vomiting (CINV)
Beyond the preview
Go deeper on NCT02400866.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT02400866.